Could This Be Your Last Chance to Buy Canopy Growth Corp. at $10?

Canopy Growth Corp. (TSX:CGC) stock has finally stopped plummeting. Could this be the start of another rally back to higher levels?

The stock of Canopy Growth Corp. (TSX:CGC) has finally calmed down after having off-the-chart volatility in November. A bit of bad news sent all marijuana stocks tumbling, but as the volatility settles, investors may be looking for an opportunity to get in on this extreme growth play.

It’s nearly impossible to calculate the company’s true intrinsic value at current levels because it’s very rare that a company is at the forefront of an emerging industry. Canopy has positioned itself to be an industry leader with some interesting acquisitions, including Mettrum Health and MedCann, both of which will increase Canopy’s production capacity over the long term.

The volatility has died down this month. Is it safe to own?

Don’t be tricked. Although the sell-off and short-term volatility appear to be over, the stock is still a very risky play, and more volatility could be on the horizon as we head into 2017. This is just the calm before the storm, and investors should be very patient playing the stock right now, because it could violently correct if negative rumours start making their way into the media.

If you are going to invest in Canopy, then make sure you understand that the long-term play may not work out for you if the sequence of news that is released works against marijuana stocks. This is a speculative gamble, and if you’re comfortable with losing most of your investment and you’re bullish on the marijuana industry, then Canopy may be a great pick, but wait until another sell-off happens next year.

What can we expect next year from Canopy? 

More acquisitions of international distributors is the most likely scenario as the company looks to position itself as the worldwide leader in marijuana production. As of now, there are no regulations restricting the company from producing and distributing its product at an international scale. The same can’t be said for Canopy’s American peers, which are to be restricted from distributing across state borders according to a policy put forth by President-elect Donald Trump.

Canopy has its sights set on Germany as the country is considering the medical applications of cannabis. The acquisition of MedCann was a very strategic one, and once marijuana is more widely accepted in Germany, then Canopy will see its top and bottom line soar into the atmosphere.

Canopy is moving fast, and the company is looking to expand internationally one country at a time. The growth story taking place here is unlike any that most investors have experienced before, but with great potential reward comes a huge amount of risk.

This is not your last chance to buy Canopy around the $10 level. I suspect that another sell-off could potentially be possible next year as marijuana traders slowly start losing their patience. Don’t follow the herd; wait until the herd falls off the cliff, then buy in.

Fool contributor Joey Frenette has no position in any stocks mentioned.

More on Investing

a person watches a downward arrow crash through the floor
Dividend Stocks

A TFSA Loss Doesn’t Create New Room: Here’s the Rebuilding Plan I’d Use

A falling investment won’t create TFSA contribution room. I’d rebuild using the room I actually have and a portfolio that…

Read more »

Forklift in a warehouse
Dividend Stocks

A 7.9% Dividend Stock for Monthly Retirement Income

This Canadian REIT trades at a 38.8% discount to a key valuation measure, and offers a 7.9% yield, paid monthly,…

Read more »

hand stacks coins
Dividend Stocks

Building a $1,000-a-Month Dividend Income Stream: What It Actually Takes

Wondering what it takes to earn $1,000/month in dividends? Here's some different scenarios and stocks that can help get you…

Read more »

A series of red ladders lead to successively higher levels
Dividend Stocks

Colliers Stock: The Engineering Business Behind the Real Estate Name

Colliers still earns from real estate, but engineering now gives investors a second business to follow.

Read more »

shopper checks her receipt
Dividend Stocks

2 Safe Canadian Stocks to Buy With $7,000

Loblaw (TSX:L) and another safety play that could be a great fit for Canadian investors seeking lower betas and greater…

Read more »

dreaming of financial success
Dividend Stocks

Telus vs. Fortis: Which Stock Would I Choose for a More Dependable Payout?

Telus pays more today after its reset. I’d choose Fortis for the payout I’d rather count on over several years.

Read more »

a person looks out a window into a cityscape
Dividend Stocks

This 3% Dividend Stock Pays Cash Out Every Month

Boardwalk REIT pays $0.15 a unit every month, a yield near 3%. See Q3 results, the buyback story and the…

Read more »

shoppers in an indoor mall
Dividend Stocks

2 Top TSX Dividend Stocks With High Yields Worth Considering Now

These TSX stocks offer high yields of over 5.5%, have sustainbale payouts, and are well-positioned to keep paying their dividends.

Read more »